Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xolair in Interstitial Cystitis/Painful Bladder Syndrome
NCT01294878Phase 3Completed
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Mar 2009
- Primary completion
- Sep 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of omalizumab in interstitial cystitis (IC), sponsored by IRCCS San Matteo Foundation. Started Mar 2009; status: completed.
02
Drugs
omalizumab
03
Conditions
interstitial cystitis (IC)
Beyond the preview
Go deeper on NCT01294878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01294878.